Back to search

Article

KMT2C is Potential Prognostic Biomarker and its Immune Regulating Roles in Pan-Cancer: A Comprehensive Analysis

2021-12-22

Abstract excerpt

<h4>Background: </h4> A member of histone lysine methyltransferases subfamily, The histone 3 lysine 4 (H3K4) monomethylase KMT2C, has mutations across many cancer types. However, the role of KMT2C in different cancers and its correlation with tumor infiltration and immune therapy indicators remain unknown. <h4>Method: </h4> Expression and mutation information of KMT2C has been analyzed through the Genotype-Tissue...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e3a89932-becd-56cb-9eb2-e9ee039aad15
DOI
10.21203/rs.3.rs-1174621/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
KMT2C is Potential Prognostic Biomarker and its Immune Regulating Roles in Pan-Cancer: A Comprehensive AnalysisDOI 10.21203/rs.3.rs-1174621/v1
Select a neighboring publication to make it the new centre.